Comparative bioavailability of L-683,453, a 5α-reductase inhibitor, from a self-emulsifying drug delivery system in Beagle dogs

International Journal of Pharmaceutics

Volumn 136, Issue 1-2, 1996, Pages 147-154

  Matuszewska, Bozena ^a   Hettrick, Lisa ^a   Bondi, Joseph V ^a   Storey, David E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Bioavailability; Food effect; L 683,453; Self emulsifying system; Volume effect

Indexed keywords

DECANOIC ACID; DODECYL SULFATE SODIUM; L 683453; METHYLCELLULOSE; OCTANOIC ACID; STEROID 5ALPHA REDUCTASE INHIBITOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; FOOD DRUG INTERACTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; SUSPENSION;

EID: 0029895433     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04496-1     Document Type: Article

References (16)

1. Charman, S.A., Charman, W.N., Rogge, M.C., Wilson, T.D., Dutko, F.J. and Pouton, C.W., Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm. Res., 9 (1992) 87 93.
2. Clarke, A.P., Booth, S.W., Storey D.E. and Matuszewska, B., Development and in vivo evaluation of a self-emulsifying formulation for a poorly soluble aza-steroid. Summary Book. Pharmaceutical Technology 13th Conference, Strasbourg. France. 12-14 April. 1994 pp. 564-568.
3. Cohen, S.M., Werrmann, J.G., Rasmusson, G.H., Tanaka, W.K., Malatesta, P.P., Prahalada, S., Jacobs, J.G., Harris, G. and Nett T.M., Comparison of the effects of new specific azasteroid inhibitors of steroid 5α-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression. The Prostate, 26 (1995) 55 71.
4. Constanzer, M.L., Matuszewski, B.K. and Bayne, W.F., High-performance liquid Chromatographic method for the determination of finasteride in human plasma at therapeutic doses. J. Chromatogr., 566 (1991) 127 134.
5. Groves, M.J. and de Galindez. D.A., The self-emulsifying action of mixed surfactants in oil. Acta Pharm. Suec., 13 (1976) 361-372.
6. Kelm, G.R., Penafiel, J.V., Deibel, R.M., Kinnett, G.O. and Meredith, M.P. The relative absorption of Tebufelone from self-emulsifying solutions in the Beagle dog. Pharm Res., 10 (1993) S-211.
7. B receptor antagonist, in dogs. Pharm. Res., 8 (1991) S-272.
8. Matuszewska, B., Bondi, J.V., Storey, D.E., Gilbert, J., Keogan, M. and Schofield, T., Effect of formulation and food on the absorption of MK-434, a 5α-reductase inhibitor, in Beagle dogs. Pharm. Res., 10 (1993) S-305.
9. McClintic, J.R., Physiology of the Human Body, 2nd Adition. Wiley. New York, (1976) p. 189.
10. Pouton, C.W., Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification. Int. J. Pharm., 27 (1985a) 335-348.
11. Pouton, C.W., Effect of inclusion of a model drug on the performance of self-emulsifying formulations. J. Pharm. Pharmacol., 37 (1985b) 1P.
12. Pouton, C.W., Wakerly, M.G. and Meakin, B.J., Self-emulsifying systems for oral delivery of drugs. Proc. Int. Symp. Control. Rel. Bioact. Mater, 14 (1987) 113-114.
13. Shah, N.H., Carvajal, M.T., Patel, C.I., Infeld, M.H. and Malick, A.W., Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. J. Int. Pharm., 106 (1994) 15-23.
14. Steingberg, N.G., Rasmusson, G.H. and Salzmann, T.N., 7β-N-Monosubstituted adamantyl/norbornanyl carbamoyl-4-aza-5α- androst-l-en-3-ones. European Patent Appl. 462662 (1991).
15. Wakerly, M.G., Pouton, C.W., Meakin, B.J. and Morton, F.S., Self-emulsification of vegetable oil-nonionic surfactant mixtures: A proposed mechanism of action. ACS Symp. Ser., 311 (1986) 242-255.
16. Wakerly, M.G., Pouton, C.W. and Meakin, B.J., Evaluation of the self-emulsifying performance of a non-ionic surfactant-vegetable oil mixture. J. Pharm. Pharmacol., 36 (1987) 6P.